Abstract:Colorectal cancer (CRC) is the second leading cause of cancer deaths in men and women combined in the United States. According to the American Cancer Society, approximately 100,000 new CRC cases and 50,000 CRC‐related deaths are estimated in 2019. A better understanding of molecular mechanisms underlying tumor initiation and progression in CRC is urgently needed. We have shown previously that the PH domain leucine‐rich‐repeat protein phosphatase (PHLPP) family of phosphatases function as tumor suppressors by inhibiting several oncogenic signaling pathways, including the PI3K/Akt and RAS/RAF signaling. In our studies to determine the role of PHLPP in regulating cellular metabolism, we uncovered a novel link between PHLPP and Drp1, a member of the dynamin family of GTPases that plays a key role in regulating mitochondrial dynamics. Phosphorylation of Drp1 at S616 has been shown to increase its activity and induce mitochondrial fission. A number of protein kinases have been implicated in phosphorylating S616 site, however, how phosphorylation of Drp1 is regulated by phosphatases remains largely unknown. We found that knockdown of PHLPP increased, whereas overexpression of PHLPP decreased, the phosphorylation of Drp1 at S616, suggesting that PHLPP may negatively regulate Drp1 activity. As a consequence, increased levels of mitochondrial fragmentation were observed in PHLPP knockdown cells. Moreover, bioinformatics analysis of normal and tumor samples in TCGA dataset showed that the expression of Drp1 (DNM1L) gene is significantly increased in colon adenocarcinoma supporting a role of Drp1 in promoting tumorigenesis in CRC. Taken together, we identified PHLPP as a regulator of Drp1‐dependent mitochondrial fission. Results from our studies will provide novel insights into the functional significance of PHLPP‐mediated regulation of mitochondrial dynamics in CRC. 5R01CA133429‐12 THE ROLE OF PHLPP IN COLON CANCER

PTPLAD1 Regulates PHB-Raf Interaction to Orchestrate Epithelial-Mesenchymal and Mitofusion-Fission Transitions in Colorectal Cancer

ANGPTL1 Attenuates Colorectal Cancer Metastasis by Up-Regulating Microrna-138

PDLIM1 Stabilizes the E-Cadherin/β-Catenin Complex to Prevent Epithelial–Mesenchymal Transition and Metastatic Potential of Colorectal Cancer Cells

PTPL1 suppresses lung cancer cell migration via inhibiting TGF-β1-induced activation of p38 MAPK and Smad 2/3 pathways and EMT

LRRC8A as a central mediator promotes colon cancer metastasis by regulating PIP5K1B/PIP2 pathway

A novel methylated cation channel TRPM4 inhibited colorectal cancer metastasis through Ca<SUP>2+</SUP>/Calpain-mediated proteolysis of FAK and suppression of PI3K/Akt/mTOR signaling pathway

PTPRB promotes metastasis of colorectal carcinoma via inducing epithelial-mesenchymal transition

The role of PHLPP in regulating mitochondrial dynamics in colorectal cancer

Effect of PTPRB on Metastasis of Colorectal Carcinoma and Induction of Epithelial-Mesenchymal Transition.

Plastin 1 drives metastasis of colorectal cancer through the IQGAP1/Rac1/ERK pathway

Protein tyrosine phosphatase PTPL1 suppresses lung cancer through Src/ERK/YAP1 signaling

PTEN depletion reduces H3K27me3 levels to promote epithelial-to-mesenchymal transition in epithelial colorectal cancer cells

Non-enzymatic Action of RRM1 Protein Upregulates PTEN Leading to Inhibition of Colorectal Cancer Metastasis.

MTHFD1 Regulates Autophagy to Promote Growth and Metastasis in Colorectal Cancer via the PI3K-AKT-mTOR Signaling Pathway

CTHRC1 promotes liver metastasis by reshaping infiltrated macrophages through physical interactions with TGF-β receptors in colorectal cancer

Cancer-Associated Fibroblasts Promote the Upregulation of PD-L1 Expression Through Akt Phosphorylation in Colorectal Cancer

Protein Tyrosine Phosphatase Receptor S Acts As a Metastatic Suppressor in Hepatocellular Carcinoma by Control of Epithermal Growth Factor Receptor-Induced Epithelial-Mesenchymal Transition.

RPL36A activates ERK pathway and promotes colorectal cancer growth

Targeting Cytosolic Phospholipase A2 Α in Colorectal Cancer Cells Inhibits Constitutively Activated Protein Kinase B (AKT) and Cell Proliferation

PHLDA2 regulates EMT and autophagy in colorectal cancer via the PI3K/AKT signaling pathway

Phosphorylation of PPDPF via IL6‐JAK2 activates the Wnt/β‐catenin pathway in colorectal cancer